Azizis A News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Azizis a. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Azizis A Today - Breaking & Trending Today

AB Science announces the signing of an exclusive licensing agreement with the University of ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
AB Science announces the signing of an exclusive licensing agreement with the University of .
AB ScienceApril 6, 2021 GMT
                                                                                                                                                                                                                                                                                                                 PRESS RELEASE
AB SCIENCE ANNOUNCES COLLABORATION WITH THE UNIVERSITY OF CHICAGO TO CONDUCT RESEARCH FOR THE PREVENTION AND TREATMENT OF COVID-19 WITH MASITINIB AND OTHER AB SCIENCE PROPRIETARY DRUGS
Paris, April 6 2021, 8am CET
AB Science SA (Euronext - FR0010557264 - AB), together with the Univ ....

United States , University Of Chicago , France General , Arthur Rouill , Jeffrey Freedman , Alain Moussy , Savas Tay , Olivier Hermine , Polsky Center , University Of Chicago Polsky Center , Pritzker School For Molecular Engineering , Scientific Committee , Nir Drayman , Pritzker School , Molecular Engineering , Des Sciences , Azizis A , Euronext Paris , Des March , Public Health , Products And Services , Coronavirus Pandemic , Product Testing , Diagnosis And Treatment , Globe Newswire , Licensing Agreements ,

AB Science announces that a new independent publication confirms that masitinib has anti-vital ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
AB Science announces that a new independent publication confirms that masitinib has anti-vital .
AB ScienceJanuary 25, 2021 GMT
NEW INDEPENDENT PUBLICATION CONFIRMS THAT MASITINIB HAS ANTI-VIRAL ACTIVITY AGAINST THE SARS-COV-2 VIRUS
IN VITRO AND IS A PROMISING CANDIDATE FOR TREATING COVID-19
Paris, 25 January 2021, 8.30am CET
AB Science SA (NYSE Euronext - FR0010557264 - AB) today announced the publication of preclinical study results with masitinib in COVID-19. Research led by scientists from the Institute of Human Virology (Guangzhou, China) has been published in the peer-reviewed journal
mBIO (a journal of the American Society for Microbiology). The article, entitled ‘Engineering a reliable and convenient SARS-CoV-2 replicon system for analysis of viral RNA synthesis and screening of antiviral inhibitors’,[1] is freely accessible online from the mBio ....

United States , France General , Arthur Rouill , Jeffrey Freedman , Savas Tay , Olivier Hermine , Yuewen Luo , American Society For Microbiology , Institute Of Human Virology Guangzhou , French Medicine Agency , Bio Is American Society For Microbiology , Human Airway Epithelial , American Academy Of Microbiology , University Of Chicago , Scientific Committee , Human Virology , American Society , Professor Yuewen Luo , Professor Olivier Hermine , Des Sciences , Professor Savas Tay , Pritzker School , Molecular Engineering , Azizis A , American Academy , Euronext Paris ,